NASDAQ:KIDS OrthoPediatrics (KIDS) Stock Forecast, Price & News $32.72 +0.35 (+1.08%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$32.22▼$32.8550-Day Range$32.37▼$44.9752-Week Range$31.88▼$53.50Volume60,981 shsAverage Volume73,675 shsMarket Capitalization$764.01 millionP/E Ratio363.56Dividend YieldN/APrice Target$53.60 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability OrthoPediatrics MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside63.8% Upside$53.60 Price TargetShort InterestBearish8.34% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews Sentiment0.54Based on 2 Articles This WeekInsider TradingSelling Shares$290,146 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.97) to ($0.88) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.23 out of 5 starsMedical Sector284th out of 966 stocksSurgical & Medical Instruments Industry37th out of 92 stocks 3.5 Analyst's Opinion Consensus RatingOrthoPediatrics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $53.60, OrthoPediatrics has a forecasted upside of 63.8% from its current price of $32.72.Amount of Analyst CoverageOrthoPediatrics has only been the subject of 3 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted8.34% of the float of OrthoPediatrics has been sold short.Short Interest Ratio / Days to CoverOrthoPediatrics has a short interest ratio ("days to cover") of 15.4, which indicates bearish sentiment.Change versus previous monthShort interest in OrthoPediatrics has recently increased by 4.80%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldOrthoPediatrics does not currently pay a dividend.Dividend GrowthOrthoPediatrics does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOrthoPediatrics has received a 52.35% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Synthetic bone grafts", "Cervical implants", and "Medical screws" products. See details.Environmental SustainabilityThe Environmental Impact score for OrthoPediatrics is -1.20. Previous Next 2.5 News and Social Media Coverage News SentimentOrthoPediatrics has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for OrthoPediatrics this week, compared to 1 article on an average week.Search Interest1 people have searched for KIDS on MarketBeat in the last 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $290,146.00 in company stock.Percentage Held by Insiders32.60% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions68.36% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for OrthoPediatrics are expected to grow in the coming year, from ($0.97) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OrthoPediatrics is 363.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 123.09.Price to Earnings Ratio vs. SectorThe P/E ratio of OrthoPediatrics is 363.56, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 131.05.Price to Book Value per Share RatioOrthoPediatrics has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OrthoPediatrics (NASDAQ:KIDS) StockOrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.Read More KIDS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KIDS Stock News HeadlinesSeptember 17, 2023 | americanbankingnews.comOrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Recommendation of "Buy" by BrokeragesSeptember 14, 2023 | finance.yahoo.comOrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company ShowcaseSeptember 23, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.September 11, 2023 | msn.comOrthoPedatrics gets FDA clearance for pediatric tibia platformSeptember 11, 2023 | finance.yahoo.comOrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | TibiaSeptember 1, 2023 | markets.businessinsider.com4 Analysts Have This to Say About OrthoPediatricsSeptember 1, 2023 | markets.businessinsider.comJMP Securities Remains a Buy on OrthoPediatrics (KIDS)August 29, 2023 | fool.comOrthoPediatrics (NASDAQ: KIDS)September 23, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.August 14, 2023 | benzinga.comOrthoPediatrics Insider Trades Send a SignalAugust 2, 2023 | msn.comJMP Securities Reiterates OrthoPediatrics (KIDS) Market Outperform RecommendationAugust 1, 2023 | msn.comNeedham Reiterates OrthoPediatrics (KIDS) Buy RecommendationAugust 1, 2023 | finance.yahoo.comCompared to Estimates, OrthoPediatrics (KIDS) Q2 Earnings: A Look at Key MetricsJuly 31, 2023 | finance.yahoo.comOrthoPediatrics Corp. Reports Second Quarter 2023 Financial ResultsJuly 24, 2023 | markets.businessinsider.comOrthoPediatrics (KIDS) Receives a Buy from Truist FinancialJuly 18, 2023 | finance.yahoo.comOrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023July 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), UnitedHealth (UNH) and OrthoPediatrics (KIDS)June 27, 2023 | benzinga.comCOO and CFO of OrthoPediatrics Sold $190K In StockJune 27, 2023 | finance.yahoo.comOrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation SystemJune 15, 2023 | finance.yahoo.comOrthoPediatrics Announces Election of George Dyer, MD to its Board of DirectorsMay 30, 2023 | finance.yahoo.comWith OrthoPediatrics Corp. (NASDAQ:KIDS) It Looks Like You'll Get What You Pay ForMay 23, 2023 | markets.businessinsider.comOrthoPediatrics (KIDS) Gets a Buy from JMP SecuritiesMay 4, 2023 | finance.yahoo.comOrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis SystemMay 1, 2023 | finance.yahoo.comOrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue GuidanceMay 1, 2023 | finance.yahoo.comOrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual MeetingApril 20, 2023 | finance.yahoo.comOrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw SystemApril 19, 2023 | finance.yahoo.comInvestors in OrthoPediatrics (NASDAQ:KIDS) have made a strong return of 158% over the past five yearsSee More Headlines Receive KIDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. Email Address KIDS Company Calendar Last Earnings7/31/2023Today9/22/2023Next Earnings (Estimated)10/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:KIDS CUSIPN/A CIK1425450 Webwww.orthopediatrics.com Phone(574) 268-6379Fax574-269-3692Employees203Year FoundedN/APrice Target and Rating Average Stock Price Forecast$53.60 High Stock Price Forecast$60.00 Low Stock Price Forecast$50.00 Forecasted Upside/Downside+63.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.09 Trailing P/E Ratio363.56 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.26 million Net Margins0.73% Pretax Margin-3.04% Return on Equity-5.03% Return on Assets-4.43% Debt Debt-to-Equity RatioN/A Current Ratio5.04 Quick Ratio2.99 Sales & Book Value Annual Sales$122.29 million Price / Sales6.25 Cash FlowN/A Price / Cash FlowN/A Book Value$16.54 per share Price / Book1.98Miscellaneous Outstanding Shares23,350,000Free Float15,739,000Market Cap$764.01 million OptionableNot Optionable Beta0.85 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Mark C. Throdahl (Age 72)Exec. Chairman Mr. David R. Bailey (Age 44)Pres, CEO & Director Comp: $588.47kMr. Fred L. Hite (Age 55)CFO, Principal Financial & Accounting Officer, COO and Director Comp: $578.75kMr. Daniel J. Gerritzen (Age 53)Exec. VP of Legal & Gen. Counsel Comp: $470.44kMr. Gregory A. Odle (Age 53)Pres of Scoliosis Comp: $484.32kMr. Kevin L. Unger CHE (Age 51)MBA/MSHA, Pres of Enabling Technologies Comp: $56.25kMr. Joseph W. Hauser (Age 41)Pres of Trauma & Deformity Correction Comp: $470.44kMr. Joel BattsSr. VP of Clinical & Regulatory AffairsMr. Mark KarshnerSr. VP of International SalesMore ExecutivesKey CompetitorsBeauty HealthNASDAQ:SKINAtrionNASDAQ:ATRINevroNYSE:NVROSI-BONENASDAQ:SIBNTreace Medical ConceptsNASDAQ:TMCIView All CompetitorsInsiders & InstitutionsCalifornia State Teachers Retirement SystemBought 735 shares on 8/21/2023Ownership: 0.088%Osaic Holdings Inc.Bought 551 shares on 8/21/2023Ownership: 0.007%Nuveen Asset Management LLCBought 401 shares on 8/16/2023Ownership: 0.160%Captrust Financial AdvisorsSold 1,990 shares on 8/15/2023Ownership: 0.041%Citadel Advisors LLCSold 1,000 shares on 8/15/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions KIDS Stock - Frequently Asked Questions Should I buy or sell OrthoPediatrics stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KIDS shares. View KIDS analyst ratings or view top-rated stocks. What is OrthoPediatrics' stock price forecast for 2023? 4 analysts have issued 1-year target prices for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $60.00. On average, they predict the company's stock price to reach $53.60 in the next twelve months. This suggests a possible upside of 63.8% from the stock's current price. View analysts price targets for KIDS or view top-rated stocks among Wall Street analysts. How have KIDS shares performed in 2023? OrthoPediatrics' stock was trading at $39.73 on January 1st, 2023. Since then, KIDS shares have decreased by 17.6% and is now trading at $32.72. View the best growth stocks for 2023 here. When is OrthoPediatrics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023. View our KIDS earnings forecast. How were OrthoPediatrics' earnings last quarter? OrthoPediatrics Corp. (NASDAQ:KIDS) posted its quarterly earnings results on Monday, July, 31st. The company reported ($0.19) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.19). The business earned $39.56 million during the quarter, compared to the consensus estimate of $39.11 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.03% and a net margin of 0.73%. What guidance has OrthoPediatrics issued on next quarter's earnings? OrthoPediatrics issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $148.00 million-$151.00 million, compared to the consensus revenue estimate of $149.28 million. What is Mark Throdahl's approval rating as OrthoPediatrics' CEO? 15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of OrthoPediatrics own? Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA). When did OrthoPediatrics IPO? (KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers. What is OrthoPediatrics' stock symbol? OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS." Who are OrthoPediatrics' major shareholders? OrthoPediatrics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (15.02%), Brown Advisory Inc. (6.88%), BlackRock Inc. (4.70%), Riverbridge Partners LLC (4.67%), Braidwell LP (3.26%) and Granahan Investment Management LLC (2.14%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback. View institutional ownership trends. How do I buy shares of OrthoPediatrics? Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OrthoPediatrics' stock price today? One share of KIDS stock can currently be purchased for approximately $32.72. How much money does OrthoPediatrics make? OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $764.01 million and generates $122.29 million in revenue each year. The company earns $1.26 million in net income (profit) each year or $0.09 on an earnings per share basis. How many employees does OrthoPediatrics have? The company employs 203 workers across the globe. How can I contact OrthoPediatrics? OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692. This page (NASDAQ:KIDS) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.